Enovis Corp
NYSE:ENOV

Watchlist Manager
Enovis Corp Logo
Enovis Corp
NYSE:ENOV
Watchlist
Price: 46.67 USD 1.08% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Enovis Corp?
Write Note

Enovis Corp
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Enovis Corp
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Enovis Corp
NYSE:ENOV
Cash from Operating Activities
$135m
CAGR 3-Years
-24%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Cash from Operating Activities
$3.8B
CAGR 3-Years
-6%
CAGR 5-Years
3%
CAGR 10-Years
8%
Boston Scientific Corp
NYSE:BSX
Cash from Operating Activities
$2.9B
CAGR 3-Years
12%
CAGR 5-Years
20%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Cash from Operating Activities
$3.8B
CAGR 3-Years
3%
CAGR 5-Years
9%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Cash from Operating Activities
$7.9B
CAGR 3-Years
-11%
CAGR 5-Years
8%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash from Operating Activities
$1.8B
CAGR 3-Years
-5%
CAGR 5-Years
6%
CAGR 10-Years
10%
No Stocks Found

Enovis Corp
Glance View

Market Cap
2.6B USD
Industry
Health Care

Enovis Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Wilmington, Delaware and currently employs 16,200 full-time employees. The company went IPO on 2008-05-08. Enovis Corporation, formerly Colfax Corporation, is a medical technology company that provides orthopedic care and fabrication technology products and services under DJO brand. The Company’s segments include Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Its fabrication technology products are marketed under several brands. The Medical Technology segment develops, manufactures and distributes medical devices and services across the continuum of patient care from injury prevention to joint replacement to the rehabilitation after surgery, injury from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, and others.

ENOV Intrinsic Value
72.78 USD
Undervaluation 36%
Intrinsic Value
Price

See Also

What is Enovis Corp's Cash from Operating Activities?
Cash from Operating Activities
135m USD

Based on the financial report for Dec 31, 2023, Enovis Corp's Cash from Operating Activities amounts to 135m USD.

What is Enovis Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-10%

The average annual Cash from Operating Activities growth rates for Enovis Corp have been -24% over the past three years , -10% over the past five years .

Back to Top